Medcan News

11th of November

11th November, 2019 – For immediate release

Medcan Australia – First imported products received

Medcan Australia is pleased to announce its first shipment of imported Medicinal Cannabis products have been received.

The receipt of these Medcan branded products validates Medcan’s supply chain and confirms Medcan’s ability to navigate the import/export process for Medicinal cannabis products.

Successful importation of Medcan’s first branded products allows:

  1. the supply of branded products into Medcan’s Australian Doctor/Pharmacist networks
  2. the supply of branded products into Medcan’s clinical trials
  3. the ability to commence stability trials
  4. an immediate additional revenue stream to support Medcan’s business development

Comments from Craig Cochran – CEO Medcan Australia:

Medcan Australia Founder, Craig Cochran said: “The receipt of our first imported range of Medcan branded products has been the result of a tireless effort from both the Medcan team and our international partners.  The regulatory requirements from both sides to firstly meet the stringent requirements of TGO93 and secondly to traverse the various Federal requirements, has been an intensive process.  It is a credit to all parties involved.” 

Craig Continued: “Medcan are now in a position to execute our short-term revenue strategy by penetrating the Australian market with Medcan branded products.  Medcan having an immediate position within the Australian market also aligns with our longer-term strategy which will allow the transition to our own locally produced and manufactured products once they come online.”

Background

Medcan Australia was founded in 2016 and was one of the first Australian companies to be licensed by the Office of Drug Control (ODC) to cultivate and produce Medicinal Cannabis, manufacture Medicinal Cannabis products and import and export Medicinal Cannabis products.  The company was founded with a single vision to provide Australian patients with high quality, fair priced Medicinal Cannabis products.

Medcan Australia are one of only a few companies in Australia to hold the full suite of ODC (Office of Drug Control) Licences, State Licences & DAWR Permit being:

1) Cultivation and Production Licence – no. MC013/17

2) Manufacture Licence – no. ML015/18

3) Research Licence – no. RL18/19

4) Import Licence – no. 1821087

5) Export Licence – no. 1821088

6) DAWR Permit – no. 0002005875

7) QLD Health Poison’s Licence – no. AG007354718

8) QLD Wholesaling Approval – no. C-MC-1289

Medcan Australia will be producing a range of high quality Medicinal Cannabis strains with varying CBD & THC profiles to suit varying medicinal applications, with all of our products manufactured under GMP certification, ensuring consistent medicine for patients.

For Further Information please contact:

Gareth Ball 

+61414860512
Po Box 4579, Springfield, QLD, Australia, 4300

gareth@medcanaustralia.com.au

10th of October

8th of October 

RAVENQUEST RECEIVES HEALTH CANADA PERMIT FOR EXPORT TO AUSTRALIA       

                                                                                                   

2nd of July 2019

2nd July 2019 Medcan Secured its Research Licence

19th of February 2019

Medcan Looking for new Investors – Press Release FEB 2019.1 (003)